A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A
- PMID: 9379439
- DOI: 10.1021/jm960873x
A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A
Abstract
Protein phosphatases play significant roles in signal transduction pathways pertaining to cell proliferation, gene expression, and neurotransmission. Serine/threonine phosphatases PP1 and PP2A, which are closely related in primary structure (approximately 50%), are inhibited by a structurally diverse group of natural toxins. As part of our study toward understanding the mechanism of inhibition displayed by these toxins, we have developed research in two directions: (1) The standardization of an assay to be used in acquisition of the structure--activity relationship of inhibition data is reported. This nonradioactive assay affords detection levels of molecular phosphate released from a phosphorylated hexapeptide in subnanomolar quantities. The comparison of our IC50 values of these inhibitors against corresponding literature data provided validation for our method. (2) Computational analysis provided a global model for binding of these inhibitors to PP1. The natural toxins were shown to possess remarkably similar three-dimensional motifs upon superimposition and van der Waals minimization within the PP1 active site.
Similar articles
-
Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.Toxicon. 1994 Mar;32(3):339-50. doi: 10.1016/0041-0101(94)90086-8. Toxicon. 1994. PMID: 8016855
-
[Naturally occurring toxins with specific inhibitory activity against protein serine/threonine phosphatases 1 and 2A].Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1091-101. Tanpakushitsu Kakusan Koso. 1998. PMID: 9655967 Review. Japanese. No abstract available.
-
Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors.J Biol Chem. 1999 Aug 6;274(32):22366-72. doi: 10.1074/jbc.274.32.22366. J Biol Chem. 1999. PMID: 10428807
-
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.J Med Chem. 2002 Mar 14;45(6):1151-75. doi: 10.1021/jm010066k. J Med Chem. 2002. PMID: 11881984 Review. No abstract available.
-
Role of phosphoprotein phosphatases in the corpus luteum: I identification and characterisation of serine/threonine phosphoprotein phosphatases in isolated rat luteal cells.J Endocrinol. 1996 Aug;150(2):205-11. doi: 10.1677/joe.0.1500205. J Endocrinol. 1996. PMID: 8869587
Cited by
-
NHE3 function and phosphorylation are regulated by a calyculin A-sensitive phosphatase.Am J Physiol Renal Physiol. 2010 Mar;298(3):F745-53. doi: 10.1152/ajprenal.00182.2009. Epub 2009 Dec 16. Am J Physiol Renal Physiol. 2010. PMID: 20015946 Free PMC article.
-
Cellular serine/threonine phosphatase activity during human cytomegalovirus infection.Virology. 2008 Oct 25;380(2):255-63. doi: 10.1016/j.virol.2008.07.028. Epub 2008 Aug 30. Virology. 2008. PMID: 18757073 Free PMC article.
-
Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2.Mol Cell Biol. 2003 Feb;23(4):1292-303. doi: 10.1128/MCB.23.4.1292-1303.2003. Mol Cell Biol. 2003. PMID: 12556489 Free PMC article.
-
Greatwall-phosphorylated Endosulfine is both an inhibitor and a substrate of PP2A-B55 heterotrimers.Elife. 2014 Mar 11;3:e01695. doi: 10.7554/eLife.01695. Elife. 2014. PMID: 24618897 Free PMC article.
-
Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells.Front Oncol. 2011 Sep 20;1:27. doi: 10.3389/fonc.2011.00027. eCollection 2011. Front Oncol. 2011. PMID: 22655237 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials